Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111942524 | 11194252 | 4 | F | 2015 | 20160909 | 20150616 | 20160914 | EXP | US-009507513-1506USA004779 | MERCK | 59.58 | YR | M | Y | 89.34000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111942524 | 11194252 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | 21995 | 100 | MG | FILM-COATED TABLET | QD | ||||||
| 111942524 | 11194252 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50 MG, BID | 21995 | 50 | MG | FILM-COATED TABLET | BID | ||||||
| 111942524 | 11194252 | 3 | SS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50/1000 MG, QD | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||||
| 111942524 | 11194252 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 111942524 | 11194252 | 5 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | UNK | 0 | ||||||||||
| 111942524 | 11194252 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | UNK | 0 | ||||||||||
| 111942524 | 11194252 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | UNK | 0 | ||||||||||
| 111942524 | 11194252 | 8 | C | PRINIVIL | LISINOPRIL | 1 | UNK | 0 | TABLET | ||||||||||
| 111942524 | 11194252 | 9 | C | LATANOPROST. | LATANOPROST | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111942524 | 11194252 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111942524 | 11194252 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111942524 | 11194252 | Abdominal pain | |
| 111942524 | 11194252 | Confusional state | |
| 111942524 | 11194252 | Constipation | |
| 111942524 | 11194252 | Diarrhoea | |
| 111942524 | 11194252 | Diverticulitis | |
| 111942524 | 11194252 | Influenza like illness | |
| 111942524 | 11194252 | Irritability | |
| 111942524 | 11194252 | Nasal congestion | |
| 111942524 | 11194252 | Oropharyngeal pain | |
| 111942524 | 11194252 | Product use issue | |
| 111942524 | 11194252 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111942524 | 11194252 | 1 | 201502 | 0 | ||
| 111942524 | 11194252 | 2 | 2016 | 0 |